Allergan’s patent deal with Native American tribe tops cornea news

Allergan’s announcement that it will transfer its patent for Restasis to a New York-based Native American tribe led the recent cornea-related news, with trial updates and drug commercialization deals also making headlines this month.Here are five of the most recent cornea/external disease stories on Healio.com/OSN:

Full Story →